Sabouraud A et al. |
Specific anti-digoxin Fab fragments: an available antidote for proscillaridin and scilliroside poisoning? |
1990 |
Hum Exp Toxicol |
pmid:2375888
|
Sich B et al. |
Pulse pressure correlates in humans with a proscillaridin A immunoreactive compound. |
1996 |
Hypertension |
pmid:8621199
|
Bonelli J et al. |
Hemodynamic effect of methylepoxyproscillaridin (P35) in patients with congestive myocardiopathy. |
1988 |
Int J Clin Pharmacol Ther Toxicol |
pmid:3410600
|
Bonelli J et al. |
The bioavailability of methylepoxyproscillaridin (P35): a new semisynthetic cardiac glycoside. |
1988 |
Int J Clin Pharmacol Ther Toxicol |
pmid:3410606
|
Terness P et al. |
The T-cell suppressive effect of bufadienolides: structural requirements for their immunoregulatory activity. |
2001 |
Int. Immunopharmacol. |
pmid:11367509
|
El-Seedi HR et al. |
The traditional medical uses and cytotoxic activities of sixty-one Egyptian plants: discovery of an active cardiac glycoside from Urginea maritima. |
2013 |
J Ethnopharmacol |
pmid:23228916
|
Alken RG and Belz GG |
A comparative dose-effect study with cardiac glycosides assessing cardiac and extracardiac responses in normal subjects. |
1984 Jul-Aug |
J. Cardiovasc. Pharmacol. |
pmid:6206318
|
Felth J et al. |
Cytotoxic effects of cardiac glycosides in colon cancer cells, alone and in combination with standard chemotherapeutic drugs. |
2009 |
J. Nat. Prod. |
pmid:19894733
|
Kojima K et al. |
Determination of proscillaridin in plasma by radioimmunoassay. |
1986 |
J. Pharmacobio-dyn. |
pmid:3783410
|
Stauch M et al. |
[Effect of proscillaridin-4'-methylether on pressure rise velocity in the left ventricle of patients with coronary heart disease (author's transl)]. |
1977 |
Klin. Wochenschr. |
pmid:330937
|